$Pulsenmore(PLSM.US) surged +93% in a single day, catalyzed by being selected by Ouma Health, a leading U.S. maternity and postpartum telemedicine platform, as the home ultrasound entry point, and FDA approval has also been granted. The story itself is true.
The question is, for such a micro-cap medical device stock, can a partnership with one major client support a doubled valuation, or will the sentiment be exhausted in just a few days? The latter is more likely — there's a long gap between a single partnership landing and actual revenue realization. Those without positions shouldn't FOMO buy on this +93% day 🙈
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
